Completed NA INTERVENTIONAL 1-arm NCT03310697

Toxicological Screening by GC-MS Among Children Admitted for a First Afebrile Seizure (CASTox)

Toxicological Screening by GC-MS Among Children Admitted for a First Afebrile Seizure (CASTox): a Pilot Study

Sponsor: University Hospital, Toulouse

Interventions Clinical examination Collection of blood and urine samples

Updated 9 times since 2017 Last updated: Oct 27, 2021 Started: Dec 19, 2017 Primary completion: Oct 6, 2020 Completion: Oct 6, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03310697, this NA trial focuses on Afebrile Seizure (Finding) and remains completed. Sponsored by University Hospital, Toulouse, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Nov 2021 [monthly]

Recruiting NA
Nov 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Sep 2019 — Nov 2020 [monthly]

Recruiting NA
May 2019 — Sep 2019 [monthly]

Recruiting NA
Jun 2018 — May 2019 [monthly]

Recruiting NA
Oct 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Toulouse

Data source: University Hospital, Toulouse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France